ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STANSBERRY ASSET MANAGEMENT, LLC | 112,467 | $517,348 | 0.09% |
| DUALITY ADVISERS, LP | 162,200 | $746,120 | 0.09% |
| Quantamental Technologies LLC | 19,570 | $90,022 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 86,795 | $399,257 | 0.08% |
| VOYA INVESTMENT MANAGEMENT LLC | 10,624,185 | $48,871,252 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 146,190 | $672 | 0.06% |
| Jump Financial, LLC | 274,502 | $1,262,709 | 0.05% |
| Nan Fung Group Holdings Ltd | 12,521 | $57,597 | 0.05% |
| Integrity Financial Corp /WA | 13,050 | $60,030 | 0.04% |
| AXQ CAPITAL, LP | 27,000 | $124,200 | 0.04% |
| Resolute Advisors LLC | 57,526 | $264,620 | 0.04% |
| FEDERATED HERMES, INC. | 3,254,353 | $14,970,024 | 0.04% |
| Virtus ETF Advisers LLC | 13,385 | $61,571 | 0.04% |
| Cedar Brook Financial Partners, LLC | 30,250 | $139,150 | 0.04% |
| XTX Topco Ltd | 44,331 | $203,923 | 0.04% |
| Trexquant Investment LP | 272,158 | $1,251,927 | 0.03% |
| SEARLE & CO. | 13,900 | $63,940 | 0.02% |
| CREDIT SUISSE AG/ | 4,572,977 | $21,035,694 | 0.02% |
| Quent Capital, LLC | 27,860 | $128,156 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 3,146,833 | $14,475 | 0.02% |
External links
This page lists ABCELLERA BIOLOGICS INC's shareholders in Q3 2023. To view ABCELLERA BIOLOGICS INC's shareholder history, click here.